Lord Mancroft – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Lord Mancroft on 2016-04-13.

To ask Her Majesty’s Government on which specific NICE guidance NHS England based its decision to restrict access to new treatments for hepatitis C to 10,000 patients in 2016–17.

Lord Prior of Brampton

The planning approach for hepatitis C is set out in the National Institute for Health and Care Excellence (NICE) Technology Appraisals 363, 364 and 365 which require Operational Delivery Networks to prioritise treatment for patients with the highest unmet clinical need. We understand from NHS England that the figure of 10,000 patients reflects NICE modelling used for its recommendations and published alongside the guidance.